Aveanna Healthcare Holdings Debt to Equity Ratio 2020-2026 | AVAH
Current and historical debt to equity ratio values for Aveanna Healthcare Holdings (AVAH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Aveanna Healthcare Holdings debt/equity for the three months ending March 31, 2026 was 6.62.
| Aveanna Healthcare Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $1.78B | $0.24B | 7.42 |
| 2025-12-31 | $1.82B | $0.19B | 9.35 |
| 2025-09-30 | $1.80B | $0.01B | 196.13 |
| 2025-06-30 | $1.78B | $-0.01B | -148.68 |
| 2025-03-31 | $1.76B | $-0.10B | -17.59 |
| 2024-12-31 | $1.79B | $-0.12B | -14.46 |
| 2024-09-30 | $1.80B | $-0.16B | -11.51 |
| 2024-06-30 | $1.78B | $-0.12B | -14.99 |
| 2024-03-31 | $1.78B | $-0.14B | -13.06 |
| 2023-12-31 | $1.74B | $-0.13B | -13.45 |
| 2023-09-30 | $1.76B | $-0.11B | -16.65 |
| 2023-06-30 | $1.75B | $-0.01B | -259.48 |
| 2023-03-31 | $1.77B | $-0.04B | -49.26 |
| 2022-12-31 | $1.72B | $-0.01B | -272.28 |
| 2022-09-30 | $1.75B | $0.23B | 7.66 |
| 2022-06-30 | $1.71B | $0.20B | 8.54 |
| 2022-03-31 | $1.71B | $0.67B | 2.57 |
| 2021-12-31 | $1.70B | $0.64B | 2.67 |
| 2021-09-30 | $1.20B | $0.75B | 1.59 |
| 2021-06-30 | $1.21B | $0.75B | 1.62 |
| 2021-03-31 | $1.53B | $0.27B | 5.62 |
| 2020-12-31 | $1.58B | $0.27B | 5.96 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.353B | $2.433B |
| Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |